Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $754.27 billion, securing the top spot among global Biotech companies. Johnson & Johnson (JNJ) and AbbVie (ABBV) follow closely behind. The data was last updated on April 19, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
401
|
 2seventy bio
TSVT
|
$0.26 B | $4.98 |
0.00%
|
-47.3%
|
United States
|
|
402
|
 Humacyte
HUMA
|
$0.26 B | $1.68 |
0.00%
|
11.6%
|
United States
|
|
403
|
 Indoco Remedies
INDOCO.NS
|
$0.26 B | $2.81 |
0.00%
|
-0.50%
|
India
|
|
404
|
 Taysha Gene Therapies
TSHA
|
$0.25 B | $1.24 |
0.00%
|
-24.0%
|
United States
|
|
405
|
 Atea Pharmaceuticals
AVIR
|
$0.25 B | $2.97 |
0.00%
|
-17.2%
|
United States
|
|
406
|
 XOMA
XOMA
|
$0.25 B | $21.18 |
0.00%
|
2.0%
|
United States
|
|
407
|
 Vanda Pharmaceuticals
VNDA
|
$0.25 B | $4.33 |
0.00%
|
-3.8%
|
United States
|
|
408
|
 Emergent BioSolutions
EBS
|
$0.25 B | $4.62 |
0.00%
|
368.1%
|
United States
|
|
409
|
 iTeos Therapeutics
ITOS
|
$0.25 B | $6.51 |
0.00%
|
-33.5%
|
United States
|
|
410
|
 Aquestive Therapeutics
AQST
|
$0.25 B | $2.51 |
0.00%
|
-31.7%
|
United States
|
|
411
|
 Avita Medical
RCEL
|
$0.24 B | $9.21 |
0.00%
|
2.9%
|
United States
|
|
412
|
 Monopar Therapeutics
MNPR
|
$0.24 B | $39.59 |
0.00%
|
1542.1%
|
United States
|
|
413
|
 Compass Therapeutics
CMPX
|
$0.24 B | $1.75 |
0.00%
|
161.7%
|
United States
|
|
414
|
 Cerus
CERS
|
$0.24 B | $1.30 |
0.00%
|
2.4%
|
United States
|
|
415
|
 Lifecore Biomedical
LFCR
|
$0.24 B | $6.41 |
0.00%
|
-6.7%
|
United States
|
|
416
|
 Abeona Therapeutics
ABEO
|
$0.24 B | $4.84 |
0.00%
|
-20.9%
|
United States
|
|
417
|
 Third Harmonic Bio
THRD
|
$0.23 B | $5.16 |
0.00%
|
-60.1%
|
United States
|
|
418
|
 OraSure Technologies
OSUR
|
$0.23 B | $2.99 |
0.00%
|
-27.9%
|
United States
|
|
419
|
 Immutep
IMMP
|
$0.22 B | $1.54 |
0.00%
|
-15.5%
|
Australia
|
|
420
|
 ACELYRIN
SLRN
|
$0.22 B | $2.20 |
0.00%
|
-60.8%
|
United States
|
|
421
|
 Corvus Pharmaceuticals
CRVS
|
$0.22 B | $3.24 |
0.00%
|
249.3%
|
United States
|
|
422
|
 OmniAb
OABI
|
$0.22 B | $1.79 |
0.00%
|
-24.1%
|
United States
|
|
423
|
 DBV Technologies
DBVT
|
$0.22 B | $7.98 |
0.00%
|
211.6%
|
France
|
|
424
|
 CARGO Therapeutics
CRGX
|
$0.21 B | $4.64 |
0.00%
|
-82.0%
|
United States
|
|
425
|
 Y-mAbs Therapeutics
YMAB
|
$0.21 B | $4.69 |
0.00%
|
-59.4%
|
United States
|
|
426
|
 Foghorn Therapeutics
FHTX
|
$0.21 B | $3.80 |
0.00%
|
4.8%
|
United States
|
|
427
|
 Oriola Oyj
OKDAV.HE
|
$0.21 B | $1.16 |
0.00%
|
-12.0%
|
Finland
|
|
428
|
 Quantum-Si
QSI
|
$0.21 B | $1.15 |
0.00%
|
23.5%
|
United States
|
|
429
|
 Terns Pharmaceuticals
TERN
|
$0.21 B | $2.40 |
0.00%
|
-7.5%
|
United States
|
|
430
|
 Nuvectis Pharma
NVCT
|
$0.21 B | $8.86 |
0.00%
|
-10.8%
|
United States
|
|
431
|
 DBV Technologies S.A.
DBV.PA
|
$0.21 B | $1.51 |
0.00%
|
-31.9%
|
France
|
|
432
|
 enGene
ENGN
|
$0.20 B | $4.00 |
0.00%
|
-60.1%
|
Canada
|
|
433
|
 Protalix BioTherapeutics
PLX
|
$0.20 B | $2.61 |
0.00%
|
128.0%
|
Israel
|
|
434
|
 Global Cord Blood
CORBF
|
$0.20 B | $0.65 |
0.00%
|
-25.9%
|
Hong Kong
|
|
435
|
 Quanterix
QTRX
|
$0.20 B | $5.15 |
0.00%
|
-52.0%
|
United States
|
|
436
|
 Design Therapeutics
DSGN
|
$0.20 B | $3.50 |
0.00%
|
9.5%
|
United States
|
|
437
|
 Ocugen
OCGN
|
$0.20 B | $0.68 |
0.00%
|
-43.5%
|
United States
|
|
438
|
 Solid Biosciences
SLDB
|
$0.20 B | $2.55 |
0.00%
|
-61.9%
|
United States
|
|
439
|
 Nightingale Health Oyj
HEALTH.HE
|
$0.20 B | $3.25 |
0.00%
|
67.6%
|
Finland
|
|
440
|
 Cellectis
CLLS
|
$0.20 B | $1.45 |
0.00%
|
-29.9%
|
France
|
|
441
|
 Gossamer Bio
GOSS
|
$0.19 B | $0.84 |
0.00%
|
57.5%
|
United States
|
|
442
|
 Amarin Corporation
AMRN
|
$0.19 B | $9.11 |
0.00%
|
-29.9%
|
Ireland
|
|
443
|
 Esperion Therapeutics
ESPR
|
$0.19 B | $0.95 |
0.00%
|
-2.6%
|
United States
|
|
444
|
 MediWound
MDWD
|
$0.18 B | $17.10 |
0.00%
|
19.0%
|
Israel
|
|
445
|
 Lexicon Pharmaceuticals
LXRX
|
$0.18 B | $0.51 |
0.00%
|
-56.1%
|
United States
|
|
446
|
 Alpha Tau Medical
DRTS
|
$0.18 B | $2.57 |
0.00%
|
28.7%
|
Israel
|
|
447
|
 Tevogen Bio
TVGN
|
$0.18 B | $0.98 |
0.00%
|
-7.2%
|
United States
|
|
448
|
 Eledon Pharmaceuticals
ELDN
|
$0.18 B | $2.99 |
0.00%
|
123.8%
|
United States
|
|
449
|
 Fulcrum Therapeutics
FULC
|
$0.18 B | $3.29 |
0.00%
|
-49.9%
|
United States
|
|
450
|
 Hester Biosciences
HESTERBIO.NS
|
$0.18 B | $20.78 |
0.00%
|
37.0%
|
India
|
|
451
|
 Genfit
GNFT
|
$0.18 B | $3.51 |
0.00%
|
-1.6%
|
France
|
|
452
|
 Codexis
CDXS
|
$0.17 B | $2.11 |
0.00%
|
46.2%
|
United States
|
|
453
|
 Voyager Therapeutics
VYGR
|
$0.17 B | $3.16 |
0.00%
|
-29.7%
|
United States
|
|
454
|
 Avacta Group
AVCT.L
|
$0.17 B | $46.54 |
0.00%
|
13.5%
|
United Kingdom
|
|
455
|
 INmune Bio
INMB
|
$0.17 B | $7.32 |
0.00%
|
-14.2%
|
United States
|
|
456
|
 Rezolute
RZLT
|
$0.17 B | $2.75 |
0.00%
|
36.7%
|
United States
|
|
457
|
 Innate Pharma
IPHA
|
$0.17 B | $1.97 |
0.00%
|
-27.4%
|
France
|
|
458
|
 Inhibrx
INBX
|
$0.17 B | $11.47 |
0.00%
|
-26.9%
|
United States
|
|
459
|
 Cellectis S.A.
ALCLS.PA
|
$0.16 B | $1.54 |
0.00%
|
-38.2%
|
France
|
|
460
|
 Neurogene
NGNE
|
$0.16 B | $11.49 |
0.00%
|
-38.3%
|
United States
|
|
461
|
 Prime Medicine
PRME
|
$0.16 B | $1.24 |
0.00%
|
-49.4%
|
United States
|
|
462
|
 Nanobiotix
NBTX
|
$0.16 B | $3.29 |
0.00%
|
-50.6%
|
France
|
|
463
|
 Annexon
ANNX
|
$0.16 B | $1.46 |
0.00%
|
-25.2%
|
United States
|
|
464
|
 Sangamo Therapeutics
SGMO
|
$0.16 B | $0.71 |
0.00%
|
127.5%
|
United States
|
|
465
|
 Cybin
CYBN
|
$0.15 B | $7.35 |
0.00%
|
-30.3%
|
Canada
|
|
466
|
 Bliss GVS Pharma
BLISSGVS.NS
|
$0.15 B | $1.46 |
0.00%
|
42.2%
|
India
|
|
467
|
 Kodiak Sciences
KOD
|
$0.15 B | $2.84 |
0.00%
|
56.1%
|
United States
|
|
468
|
 AC Immune
ACIU
|
$0.15 B | $1.48 |
0.00%
|
13.2%
|
Switzerland
|
|
469
|
 Silence Therapeutics
SLN
|
$0.15 B | $3.14 |
0.00%
|
-75.1%
|
United Kingdom
|
|
470
|
 Molecular Partners
MOLN
|
$0.15 B | $3.97 |
0.00%
|
23.7%
|
Switzerland
|
|
471
|
 Journey Medical
DERM
|
$0.14 B | $6.25 |
0.00%
|
48.0%
|
United States
|
|
472
|
 Compugen
CGEN
|
$0.14 B | $1.47 |
0.00%
|
17.5%
|
Israel
|
|
473
|
 Perspective Therapeutics
CATX
|
$0.14 B | $1.94 |
0.00%
|
-78.8%
|
United States
|
|
474
|
 Profound Medical
PROF
|
$0.14 B | $4.78 |
0.00%
|
-13.7%
|
Canada
|
|
475
|
 Protara Therapeutics
TARA
|
$0.14 B | $3.90 |
0.00%
|
38.7%
|
United States
|
|
476
|
 Puma Biotechnology
PBYI
|
$0.14 B | $2.86 |
0.00%
|
-46.2%
|
United States
|
|
477
|
 4D Molecular Therapeutics
FDMT
|
$0.14 B | $3.06 |
0.00%
|
-79.9%
|
United States
|
|
478
|
 Tango Therapeutics
TNGX
|
$0.14 B | $1.29 |
0.00%
|
-62.7%
|
United States
|
|
479
|
 Sight Sciences
SGHT
|
$0.14 B | $2.66 |
0.00%
|
-50.3%
|
United States
|
|
480
|
 Regulus Therapeutics
RGLS
|
$0.14 B | $2.06 |
0.00%
|
-45.5%
|
United States
|
|
481
|
 Aldeyra Therapeutics
ALDX
|
$0.13 B | $2.19 |
0.00%
|
52.4%
|
United States
|
|
482
|
 Korro Bio
KRRO
|
$0.13 B | $13.90 |
0.00%
|
-52.9%
|
United States
|
|
483
|
 Coherus BioSciences
CHRS
|
$0.13 B | $1.12 |
0.00%
|
-46.3%
|
United States
|
|
484
|
 scPharmaceuticals
SCPH
|
$0.13 B | $2.57 |
0.00%
|
-26.7%
|
United States
|
|
485
|
 Nkarta
NKTX
|
$0.13 B | $1.81 |
0.00%
|
-71.7%
|
United States
|
|
486
|
 Sera Prognostics
SERA
|
$0.13 B | $3.40 |
0.00%
|
-54.5%
|
United States
|
|
487
|
 Lyell Immunopharma
LYEL
|
$0.13 B | $0.43 |
0.00%
|
-77.0%
|
United States
|
|
488
|
 Lucid Diagnostics
LUCD
|
$0.13 B | $1.21 |
0.00%
|
73.1%
|
United States
|
|
489
|
 Fate Therapeutics
FATE
|
$0.13 B | $1.11 |
0.00%
|
-73.8%
|
United States
|
|
490
|
 Tiziana Life Sciences
TLSA
|
$0.13 B | $1.07 |
0.00%
|
-1.3%
|
United Kingdom
|
|
491
|
 Sensorion SA
ALSEN.PA
|
$0.13 B | $0.19 |
0.00%
|
-13.5%
|
France
|
|
492
|
 Aclaris Therapeutics
ACRS
|
$0.12 B | $1.14 |
0.00%
|
95.9%
|
United States
|
|
493
|
 Larimar Therapeutics
LRMR
|
$0.12 B | $1.91 |
0.00%
|
-47.3%
|
United States
|
|
494
|
 ProQR
PRQR
|
$0.12 B | $1.14 |
0.00%
|
21.0%
|
Netherlands
|
|
495
|
 ADC Therapeutics
ADCT
|
$0.12 B | $1.21 |
0.00%
|
-65.8%
|
Switzerland
|
|
496
|
 Contineum Therapeutics
CTNM
|
$0.12 B | $4.62 |
0.00%
|
-47.6%
|
United States
|
|
497
|
 Sellas Life Sciences
SLS
|
$0.12 B | $1.31 |
0.00%
|
-16.9%
|
United States
|
|
498
|
 Greenwich LifeSciences
GLSI
|
$0.12 B | $8.95 |
0.00%
|
-3.6%
|
United States
|
|
499
|
 Nektar Therapeutics
NKTR
|
$0.12 B | $0.64 |
0.00%
|
-48.5%
|
United States
|
|
500
|
 Eurofins-Cerep SA
ALECR.PA
|
$0.12 B | $23475.78 |
0.00%
|
-5.5%
|
France
|
|
501
|
 Seer
SEER
|
$0.12 B | $1.97 |
0.00%
|
37.7%
|
United States
|
|
502
|
 Ironwood Pharmaceuticals
IRWD
|
$0.12 B | $0.73 |
0.00%
|
-78.0%
|
United States
|
|
503
|
 Theratechnologies
THTX
|
$0.12 B | $2.52 |
0.00%
|
30.6%
|
Canada
|
|
504
|
 Carbios SAS
ALCRB.PA
|
$0.11 B | $6.82 |
0.00%
|
-69.1%
|
France
|
|
505
|
 Procaps Group
PROC
|
$0.11 B | $1.39 |
0.00%
|
-44.6%
|
Luxembourg
|
|
506
|
 Orchestra BioMed
OBIO
|
$0.11 B | $2.85 |
0.00%
|
24.0%
|
United States
|
|
507
|
 Aiforia Technologies Oyj
AIFORIA.HE
|
$0.11 B | $3.77 |
0.00%
|
-0.82%
|
Finland
|
|
508
|
 Enanta Pharmaceuticals
ENTA
|
$0.11 B | $5.10 |
0.00%
|
-63.5%
|
United States
|
|
509
|
 Nanoform Finland Oyj
NANOFH.HE
|
$0.11 B | $1.27 |
0.00%
|
-54.8%
|
Finland
|
|
510
|
 Tonix Pharmaceuticals
TNXP
|
$0.11 B | $15.71 |
0.00%
|
-97.7%
|
United States
|
|
511
|
 Editas Medicine
EDIT
|
$0.11 B | $1.28 |
0.00%
|
-78.6%
|
United States
|
|
512
|
 Neumora Therapeutics
NMRA
|
$0.10 B | $0.65 |
0.00%
|
-82.9%
|
United States
|
|
513
|
 Instil Bio
TIL
|
$0.10 B | $15.45 |
0.00%
|
86.9%
|
United States
|
|
514
|
 Senti Biosciences
SNTI
|
$0.10 B | $3.88 |
0.00%
|
43.1%
|
United States
|
|
515
|
 Genelux
GNLX
|
$98.90 M | $2.63 |
0.00%
|
36.4%
|
United States
|
|
516
|
 BioPorto A/S
BIOPOR.CO
|
$97.10 M | $0.23 |
0.00%
|
21.1%
|
Denmark
|
|
517
|
 Nautilus Biotechnology
NAUT
|
$95.62 M | $0.76 |
0.00%
|
-29.8%
|
United States
|
|
518
|
 Zomedica Pharmaceuticals
ZOM
|
$95.35 M | $0.03 |
0.00%
|
-7.3%
|
United States
|
|
519
|
 Aadi Bioscience
AADI
|
$94.89 M | $1.95 |
0.00%
|
40.0%
|
United States
|
|
520
|
 Immunic
IMUX
|
$93.90 M | $0.98 |
0.00%
|
-21.9%
|
United States
|
|
521
|
 Lineage Cell Therapeutics
LCTX
|
$93.63 M | $0.41 |
0.00%
|
-42.5%
|
United States
|
|
522
|
 OptiNose
OPTN
|
$92.87 M | $9.17 |
0.00%
|
-63.1%
|
United States
|
|
523
|
 Zentalis Pharmaceuticals
ZNTL
|
$92.64 M | $1.29 |
0.00%
|
-84.2%
|
United States
|
|
524
|
 Alector
ALEC
|
$91.17 M | $0.92 |
0.00%
|
-68.1%
|
United States
|
|
525
|
 Lexeo Therapeutics
LXEO
|
$89.96 M | $2.71 |
0.00%
|
-63.5%
|
United States
|
|
526
|
 XBiotech
XBIT
|
$89.63 M | $2.94 |
0.00%
|
-58.2%
|
United States
|
|
527
|
 Pliant Therapeutics
PLRX
|
$89.41 M | $1.46 |
0.00%
|
-75.6%
|
United States
|
|
528
|
 C4 Therapeutics
CCCC
|
$88.74 M | $1.25 |
0.00%
|
-50.9%
|
United States
|
|
529
|
 iCAD
ICAD
|
$88.12 M | $3.22 |
0.00%
|
136.8%
|
United States
|
|
530
|
 Coya Therapeutics
COYA
|
$87.97 M | $5.26 |
0.00%
|
-13.9%
|
United States
|
|
531
|
 Oramed Pharmaceuticals
ORMP
|
$87.83 M | $2.15 |
0.00%
|
-6.9%
|
United States
|
|
532
|
 Anixa Biosciences
ANIX
|
$87.58 M | $2.72 |
0.00%
|
0.66%
|
United States
|
|
533
|
 Galectin Therapeutics
GALT
|
$87.19 M | $1.38 |
0.00%
|
-57.5%
|
United States
|
|
534
|
 CervoMed
CRVO
|
$85.29 M | $9.80 |
0.00%
|
-90.8%
|
United States
|
|
535
|
 HilleVax
HLVX
|
$84.74 M | $1.69 |
0.00%
|
-86.0%
|
United States
|
|
536
|
 Zura Bio
ZURA
|
$84.10 M | $1.23 |
0.00%
|
-54.4%
|
United States
|
|
537
|
 TScan Therapeutics
TCRX
|
$81.49 M | $1.44 |
0.00%
|
-69.9%
|
United States
|
|
538
|
 Entera Bio
ENTX
|
$81.30 M | $1.79 |
0.00%
|
18.5%
|
Israel
|
|
539
|
 Vor Biopharma
VOR
|
$81.15 M | $0.65 |
0.00%
|
-24.2%
|
United States
|
|
540
|
 Atossa Therapeutics
ATOS
|
$80.49 M | $0.62 |
0.00%
|
-42.2%
|
United States
|
|
541
|
 Kyverna Therapeutics
KYTX
|
$80.39 M | $1.86 |
0.00%
|
-84.6%
|
United States
|
|
542
|
 Biodesix
BDSX
|
$80.14 M | $0.55 |
0.00%
|
-26.4%
|
United States
|
|
543
|
 Vigil Neuroscience
VIGL
|
$79.81 M | $1.71 |
0.00%
|
-6.7%
|
United States
|
|
544
|
 Aerovate Therapeutics
AVTE
|
$79.71 M | $2.75 |
0.00%
|
-89.0%
|
United States
|
|
545
|
 MacroGenics
MGNX
|
$79.49 M | $1.26 |
0.00%
|
-83.5%
|
United States
|
|
546
|
 ESSA Pharma
EPIX
|
$79.46 M | $1.79 |
0.00%
|
-73.0%
|
Canada
|
|
547
|
 MDxHealth
MDXH
|
$79.20 M | $1.60 |
0.00%
|
-20.4%
|
Belgium
|
|
548
|
 Adocia SA
ADOC.PA
|
$79.21 M | $4.39 |
-13.7%
|
-55.6%
|
France
|
|
549
|
 Vaxart
VXRT
|
$78.48 M | $0.34 |
0.00%
|
-9.0%
|
United States
|
|
550
|
 Veru
VERU
|
$78.20 M | $0.53 |
0.00%
|
-54.9%
|
United States
|
|
551
|
 Ventyx Biosciences
VTYX
|
$76.11 M | $1.07 |
0.00%
|
-61.2%
|
United States
|
|
552
|
 Context Therapeutics
CNTX
|
$75.63 M | $0.84 |
0.00%
|
-38.4%
|
United States
|
|
553
|
 Nykode Therapeutics
NYKD.OL
|
$74.95 M | $0.23 |
0.00%
|
-81.5%
|
Norway
|
|
554
|
 Telomir Pharmaceuticals
TELO
|
$73.81 M | $2.48 |
0.00%
|
-20.2%
|
United States
|
|
555
|
 Corbus Pharmaceuticals
CRBP
|
$73.76 M | $6.03 |
0.00%
|
-74.1%
|
United States
|
|
556
|
 Tenaya Therapeutics
TNYA
|
$73.16 M | $0.45 |
0.00%
|
-79.7%
|
United States
|
|
557
|
 IGM Biosciences
IGMS
|
$72.93 M | $1.22 |
0.00%
|
-79.6%
|
United States
|
|
558
|
 Adagene
ADAG
|
$72.08 M | $1.53 |
0.00%
|
-30.4%
|
China
|
|
559
|
 InflaRx
IFRX
|
$71.16 M | $1.06 |
0.00%
|
46.0%
|
Germany
|
|
560
|
 Sagimet Biosciences
SGMT
|
$71.15 M | $2.21 |
0.00%
|
13.4%
|
United States
|
|
561
|
 MediciNova
MNOV
|
$71.12 M | $1.45 |
0.00%
|
39.6%
|
United States
|
|
562
|
 Genenta Science
GNTA
|
$70.96 M | $3.88 |
0.00%
|
10.7%
|
Italy
|
|
563
|
 Cassava Sciences
SAVA
|
$69.56 M | $1.44 |
0.00%
|
-88.7%
|
United States
|
|
564
|
 Achieve Life Sciences
ACHV
|
$69.02 M | $1.99 |
0.00%
|
-22.4%
|
Canada
|
|
565
|
 I-Mab Biopharma
IMAB
|
$68.88 M | $0.85 |
0.00%
|
-43.3%
|
China
|
|
566
|
 Rani Therapeutics
RANI
|
$68.80 M | $1.17 |
0.00%
|
-78.7%
|
United States
|
|
567
|
 Clearside Biomedical
CLSD
|
$66.34 M | $0.86 |
0.00%
|
-22.7%
|
United States
|
|
568
|
 InterCure
INCR
|
$64.86 M | $1.38 |
0.00%
|
-36.0%
|
Israel
|
|
569
|
 Seres Therapeutics
MCRB
|
$64.51 M | $0.37 |
0.00%
|
25.7%
|
United States
|
|
570
|
 Cytosorbents
CTSO
|
$64.38 M | $1.03 |
0.00%
|
22.2%
|
United States
|
|
571
|
 Inovio Pharmaceuticals
INO
|
$63.81 M | $1.74 |
0.00%
|
-80.8%
|
United States
|
|
572
|
 Adlai Nortye
ANL
|
$63.10 M | $1.71 |
0.00%
|
-84.4%
|
|
|
573
|
 Vivani Medical
VANI
|
$62.80 M | $1.06 |
0.00%
|
-29.9%
|
United States
|
|
574
|
 Adaptimmune Therapeutics
ADAP
|
$61.27 M | $0.24 |
0.00%
|
-38.6%
|
United Kingdom
|
|
575
|
 Adverum Biotechnologies
ADVM
|
$61.21 M | $2.93 |
0.00%
|
-60.8%
|
United States
|
|
576
|
 Alto Neuroscience
ANRO
|
$61.18 M | $2.26 |
0.00%
|
-75.1%
|
United States
|
|
577
|
 Invivyd
IVVD
|
$61.18 M | $0.51 |
0.00%
|
-28.3%
|
United States
|
|
578
|
 VistaGen Therapeutics
VTGN
|
$60.90 M | $2.11 |
0.00%
|
-42.3%
|
United States
|
|
579
|
 Reneo Pharmaceuticals
RPHM
|
$60.84 M | $18.20 |
0.00%
|
7.7%
|
United States
|
|
580
|
 Nectar Lifesciences
NECLIFE.NS
|
$59.92 M | $0.27 |
0.00%
|
11.6%
|
India
|
|
581
|
 Fractyl Health
GUTS
|
$59.68 M | $1.22 |
0.00%
|
-77.2%
|
United States
|
|
582
|
 Jasper Therapeutics
JSPR
|
$59.64 M | $3.97 |
0.00%
|
-73.4%
|
United States
|
|
583
|
 Pyxis Oncology
PYXS
|
$59.33 M | $0.96 |
0.00%
|
-70.6%
|
United States
|
|
584
|
 Inozyme Pharma
INZY
|
$59.07 M | $0.92 |
0.00%
|
-68.1%
|
United States
|
|
585
|
 Bioretec Oy
BRETEC.HE
|
$59.07 M | $2.40 |
0.00%
|
-5.4%
|
Finland
|
|
586
|
 Assertio Therapeutics
ASRT
|
$58.46 M | $0.61 |
0.00%
|
-5.7%
|
United States
|
|
587
|
 Carmat SA
ALCAR.PA
|
$58.24 M | $1.01 |
0.00%
|
-74.2%
|
France
|
|
588
|
 Amoeba SA
ALMIB.PA
|
$58.16 M | $1.17 |
0.00%
|
104.3%
|
France
|
|
589
|
 Cue Biopharma
CUE
|
$57.42 M | $0.76 |
0.00%
|
-15.3%
|
United States
|
|
590
|
 Median Technologies SA
ALMDT.PA
|
$57.51 M | $2.81 |
0.00%
|
-18.0%
|
France
|
|
591
|
 Renovaro Biosciences
RENB
|
$57.26 M | $0.35 |
0.00%
|
-65.0%
|
United States
|
|
592
|
 Metagenomi
MGX
|
$56.82 M | $1.52 |
0.00%
|
-63.6%
|
United States
|
|
593
|
 Acrivon Therapeutics
ACRV
|
$56.75 M | $1.81 |
0.00%
|
-40.9%
|
United States
|
|
594
|
 IO Biotech
IOBT
|
$56.66 M | $0.86 |
0.00%
|
-35.3%
|
Denmark
|
|
595
|
 Cabaletta Bio
CABA
|
$55.82 M | $1.10 |
0.00%
|
-81.0%
|
United States
|
|
596
|
 Inotiv
NOTV
|
$55.55 M | $1.64 |
0.00%
|
-7.2%
|
United States
|
|
597
|
 Acumen Pharmaceuticals
ABOS
|
$54.56 M | $0.90 |
0.00%
|
-55.6%
|
United States
|
|
598
|
 Kronos Bio
KRON
|
$54.14 M | $0.89 |
0.00%
|
-1.3%
|
United States
|
|
599
|
 Akoya Biosciences
AKYA
|
$54.05 M | $1.09 |
0.00%
|
-40.0%
|
United States
|
|
600
|
 Rafael Holdings
RFL
|
$53.84 M | $1.68 |
0.00%
|
19.5%
|
United States
|